Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Prescient Therapeutics (PTX) shares

Learn how to easily invest in Prescient Therapeutics shares.

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

A$0.23
current price
A$-0.005
change
-2.1277%
change %

How to buy shares in Prescient Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Prescient Therapeutics. Find the share by name or ticker symbol: PTX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Prescient Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of A$0.23, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Prescient Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Prescient Therapeutics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Price details for Prescient Therapeutics (PTX)

Open A$0.235 Previous close A$0.235
High A$0.24 Change A$-0.005
Low A$0.225 Change % -2.1277%
Close A$0.23 Timestamp 1640905200
Volume N/A GMT offset 0

Prescient Therapeutics stock price

Use our graph to track the performance of PTX stocks over time.

Prescient Therapeutics company summary

Information last updated 2022-01-16.

Prescient Therapeutics (PTX) is a leading Biotechnology business based in Australia. Prescient Therapeutics (PTX) is listed on the ASX and employs 0 staff.

Profile

Industry Biotechnology Currency symbol A$
Code PTX Country name Australia
Type Common Stock Country ISO AU
Name Prescient Therapeutics Limited ISIN AU000000PTX3
Exchange AU CUSIP N/A
Currency code AUD Sector Healthcare
Currency name Australian Dollar Full-time employees 0

Detailed company information

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase II clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. Prescient Therapeutics Limited has a collaboration agreement with Carina Biotech to develop cell therapies. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site